Estimating the demand for radiotherapy from the evidence: A review of changes from 2003 to 2012

被引：420
作者：
Barton, Michael B. [1 ,2 ,3 ]
Jacob, Susannah [1 ,2 ,3 ]
Shafiq, Jesmin [1 ,2 ,3 ]
Wong, Karen [1 ,2 ,3 ]
Thompson, Stephen R. [3 ,4 ]
Hanna, Timothy P. [1 ,2 ,3 ]
Delaney, Geoff P. [1 ,2 ,3 ]
机构：
[1] Ingham Inst Appl Med Res, Sydney, NSW 2170, Australia
[2] Collaborat Canc Outcomes Res & Evaluat, Sydney, NSW, Australia
[3] Univ NSW, Fac Med, Sydney, NSW, Australia
[4] Prince Wales Hosp, Sydney, NSW, Australia
来源：
RADIOTHERAPY AND ONCOLOGY | 2014年 / 112卷 / 01期
关键词：
Radiotherapy; Utilisation; Evidence-based practice; Standards; OPTIMAL UTILIZATION RATES; HEMATOLOGIC MALIGNANCIES; GYNECOLOGIC CARCINOMA; BENCHMARKING APPROACH; CANCER RADIOTHERAPY; CLINICAL GUIDELINES; GENERAL-POPULATION; PROSTATE-CANCER; BREAST-CANCER; LUNG-CANCER;
D O I：
10.1016/j.radonc.2014.03.024
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background and Purpose: In 2003 we estimated that 52.3% of new cases of cancer in Australia had an indication for external beam radiotherapy at least once at some time during the course of their illness. This update reviews the contemporary evidence to define the optimal proportion of new cancers that would benefit from radiotherapy as part of their treatment and estimates the changes to the optimal radiotherapy utilisation rate from 2003 to 2012. Materials and Methods: National and international guidelines were reviewed for external beam radiotherapy indications in the management of cancers. Epidemiological data on the proportion of new cases of cancer with each indication for radiotherapy were identified. Indications and epidemiological data were merged to develop an optimal radiotherapy utilisation tree. Univariate and Monte Carlo simulations were used in sensitivity analysis. Results: The overall optimal radiotherapy utilisation rate (external beam radiotherapy) for all registered cancers in Australia changed from 52.3% in 2003 to 48.3% in 2012. Overall 8.9% of all cancer patients in Australia have at least one indication for concurrent chemo-radiotherapy during the course of their illness. Conclusions: The reduction in the radiotherapy utilisation rate was due to changes in epidemiological data, changes to radiotherapy indications and refinements of the model structure. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：140 / 144
页数：5
相关论文
共 37 条
[1]  
Allum WH, 2002, GUT, V50, P1
[2]  
Anandadas CN, 2010, BJU INT, V107
[3]  
[Anonymous], NCCN Clinical Practice Guidelines in Oncology - Breast Cancer
[4]  
Australian Institute of Health and Welfare (AIHW), 2011, AUSTR CANC INC MORT
[5]  
Barton MB, 2003, CANC SERVICES FRAMEW
[6]   A decade of investment in radiotherapy in New South Wales: Why does the gap between optimal and actual persist? [J].
Barton, Michael B. ;
Delaney, Geoff P. .
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2011, 55 (04) :433-441
[7]   Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project [J].
Bentzen, SM ;
Heeren, G ;
Cottier, B ;
Slotman, B ;
Glimelius, B ;
Lievens, Y ;
van den Bogaert, W .
RADIOTHERAPY AND ONCOLOGY, 2005, 75 (03) :355-365
[8]   Estimating the optimal radiotherapy utilization for carcinoma of the central nervous system, thyroid carcinoma, and carcinoma of unknown primary origin from evidence-based clinical guidelines [J].
Delaney, G ;
Jacob, S ;
Barton, M .
CANCER, 2006, 106 (02) :453-465
[9]   The role of radiotherapy in cancer treatment - Estimating optimal utilization from a review of evidence-based clinical guidelines [J].
Delaney, G ;
Jacob, S ;
Featherstone, C ;
Barton, M .
CANCER, 2005, 104 (06) :1129-1137
[10]   Estimation of an optimal external beam radiotherapy utilization rate for head and neck carcinoma [J].
Delaney, G ;
Jacob, S ;
Barton, M .
CANCER, 2005, 103 (11) :2216-2227
1234